CTOs on the Move

Anspach Holdings

www.anspach.com

 
The Anspach Effort, Inc. is a successful, continuously evolving business whose focus concentrates on high-speed instrumentation for Neurosurgery, Neurotology, Otology, and Orthopedics. The company is committed to providing product quality, technology,
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.anspach.com
  • 4500 Riverside Dr
    Palm Beach Gardens, FL USA 33410
  • Phone: 561.627.1080

Executives

Name Title Contact Details

Similar Companies

CeQur

CeQur is dedicated to helping people with type 2 diabetes manage their disease by developing and commercializing simple drug delivery devices that can be easily integrated into daily life. The company`s lead product, PaQ, is a wearable insulin delivery device that delivers both basal and bolus insulin for 3 days at a time. Its simple, discreet design enables people to easily experience the benefits of intensive insulin therapy, while remaining free from the burdens of daily insulin injections. CeQur SA was established in January 2008 as a spinout from Danfoss A/S, a global Danish industrial products group that developed the initial concept of the CeQur technology. CeQur recently completed a clinical study evaluating PaQ among people with type 2 diabetes with positive results. The company has advanced the technology to a commercial product obtaining a CE mark for PaQ in 2012. CeQur is headquartered in Horw, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.

Automated Medical Products Co

Automated Medical Products Co is a Edison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IMEDCO America

IMEDCO America is a Noblesville, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

1-800 Wheelchair.com

1-800 Wheelchair.com is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Impedimed

ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed`s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.